FR2988857B1 - Procede de determination de la resistance cellulaire aux medicaments. - Google Patents

Procede de determination de la resistance cellulaire aux medicaments.

Info

Publication number
FR2988857B1
FR2988857B1 FR1252922A FR1252922A FR2988857B1 FR 2988857 B1 FR2988857 B1 FR 2988857B1 FR 1252922 A FR1252922 A FR 1252922A FR 1252922 A FR1252922 A FR 1252922A FR 2988857 B1 FR2988857 B1 FR 2988857B1
Authority
FR
France
Prior art keywords
medicaments
cell resistance
determining cell
determining
resistance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1252922A
Other languages
English (en)
Other versions
FR2988857A1 (fr
Inventor
Celine Boutin
Patrick Berthault
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA, Commissariat a lEnergie Atomique et aux Energies Alternatives CEA filed Critical Commissariat a lEnergie Atomique CEA
Priority to FR1252922A priority Critical patent/FR2988857B1/fr
Publication of FR2988857A1 publication Critical patent/FR2988857A1/fr
Application granted granted Critical
Publication of FR2988857B1 publication Critical patent/FR2988857B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46NMR spectroscopy
    • G01R33/465NMR spectroscopy applied to biological material, e.g. in vitro testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01RMEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00Arrangements or instruments for measuring magnetic variables
    • G01R33/20Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48NMR imaging systems
    • G01R33/54Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Signal Processing (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR1252922A 2012-03-30 2012-03-30 Procede de determination de la resistance cellulaire aux medicaments. Expired - Fee Related FR2988857B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1252922A FR2988857B1 (fr) 2012-03-30 2012-03-30 Procede de determination de la resistance cellulaire aux medicaments.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1252922A FR2988857B1 (fr) 2012-03-30 2012-03-30 Procede de determination de la resistance cellulaire aux medicaments.

Publications (2)

Publication Number Publication Date
FR2988857A1 FR2988857A1 (fr) 2013-10-04
FR2988857B1 true FR2988857B1 (fr) 2015-02-20

Family

ID=46514542

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1252922A Expired - Fee Related FR2988857B1 (fr) 2012-03-30 2012-03-30 Procede de determination de la resistance cellulaire aux medicaments.

Country Status (1)

Country Link
FR (1) FR2988857B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9711082A (pt) * 1996-03-29 2000-01-11 Lawrence Berkeley National Lab Realce de rmn emri na presença de gases mopbres hiperpolarizados.
US5809801A (en) * 1996-03-29 1998-09-22 The Trustees Of Princeton University Cryogenic accumulator for spin-polarized xenon-129
US6125654A (en) * 1998-10-16 2000-10-03 Syracuse University Bulk production and usage of hyperpolarized 129 Xenon
WO2005086932A2 (fr) * 2004-03-10 2005-09-22 University Of Virginia Patent Foundation Systeme de resonance magnetique nucleaire a echange pondere faisant intervenir du xenon 129 et procede associe

Also Published As

Publication number Publication date
FR2988857A1 (fr) 2013-10-04

Similar Documents

Publication Publication Date Title
SG11201604198YA (en) Methods for rna analysis
EP2871470A4 (fr) Biocapteur électrochimique avec précision améliorée
BR112014032116A2 (pt) método.
DK3363806T3 (da) Glycokonjugationsfremgangsmåde
BR112015008210A2 (pt) métodos e sistemas de concentrador de oxigênio dual.
GB201218555D0 (en) Immunoassay using electrochemical detection
EP2833144A4 (fr) Procédé de détection d'une substance biologique
HK1217735A1 (zh) 用於單分子分析的方法
EP2966179A4 (fr) Procédé de détection d'adn méthylé
FR2964459B1 (fr) Procede de cartographie de la concentration en oxygene
ITRM20120383A1 (it) Metodo e kit per la rivelazione di anticorpi.
EP2832465A4 (fr) Procédé d'analyse de formage sous pression
EP3080702A4 (fr) Techniques de détection de conditions de course
BR112014010125A2 (pt) sistema eletroquímico
HK1216760A1 (zh) 用於靶標分析的螢光傳感器、用於靶標分析的試劑盒、和使用其的靶標分析方法
DK2861753T3 (da) Evalueringssystem til mikroorganismer
FR2993074B1 (fr) Procede de tatouage de livres numeriques
BR112016009753A2 (pt) método de cultura de células.
FR2974722B1 (fr) Procede de determination de la distance de lecture
HK1219775A1 (zh) 確定細胞療法的臨牀反應的淋巴細胞生物標記物
EP2844773A4 (fr) Analyse de biomarqueurs utilisant la scodaphorèse
HK1207108A1 (en) Method for obtaining monocytes or nk cells nk
BR112014029259A2 (pt) método, aparelho e produto eletrolítico
BR112014016917A8 (pt) processamento de células
DK2844988T3 (da) Elektrokemisk detektionsfremgangsmåde

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

ST Notification of lapse

Effective date: 20221105